{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T09:13:44Z","timestamp":1793092424397,"version":"4.5.0"},"reference-count":12,"publisher":"Oxford University Press (OUP)","issue":"9","license":[{"start":{"date-parts":[[2018,5,17]],"date-time":"2018-05-17T00:00:00Z","timestamp":1526515200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000265","name":"Medical Research Council","doi-asserted-by":"publisher","award":["G1100449"],"award-info":[{"award-number":["G1100449"]}],"id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000272","name":"National Institute for Health Research","doi-asserted-by":"publisher","award":["ACF-2016-20-001"],"award-info":[{"award-number":["ACF-2016-20-001"]}],"id":[{"id":"10.13039\/501100000272","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002141","name":"Public Health England","doi-asserted-by":"publisher","award":["HPRU-2012\u201310047"],"award-info":[{"award-number":["HPRU-2012\u201310047"]}],"id":[{"id":"10.13039\/501100002141","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000272","name":"National Institute for Health Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000272","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018,10,15]]},"DOI":"10.1093\/cid\/ciy401","type":"journal-article","created":{"date-parts":[[2018,5,9]],"date-time":"2018-05-09T15:13:16Z","timestamp":1525878796000},"page":"1434-1436","source":"Crossref","is-referenced-by-count":199,"title":["Polyspecific Intravenous Immunoglobulin in Clindamycin-treated Patients With Streptococcal Toxic Shock Syndrome: A Systematic Review and Meta-analysis"],"prefix":"10.1093","volume":"67","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1163-8654","authenticated-orcid":false,"given":"Tom","family":"Parks","sequence":"first","affiliation":[{"name":"London School of Hygiene and Tropical Medicine, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clare","family":"Wilson","sequence":"additional","affiliation":[{"name":"Imperial College London, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nigel","family":"Curtis","sequence":"additional","affiliation":[{"name":"Royal Children\u2019s Hospital, Melbourne, Victoria, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Norrby-Teglund","sequence":"additional","affiliation":[{"name":"Karolinska Institutet, Stockholm, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiranee","family":"Sriskandan","sequence":"additional","affiliation":[{"name":"Imperial College London, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2018,5,18]]},"reference":[{"key":"key\n\t\t\t\t20181015010315626_CIT0001","doi-asserted-by":"crossref","first-page":"69","DOI":"10.3201\/eid0103.950301","article-title":"Streptococcal toxic-shock syndrome: spectrum of disease, pathogenesis, and new concepts in treatment","volume":"1","author":"Stevens","year":"1995","journal-title":"Emerg Infect Dis"},{"key":"key\n\t\t\t\t20181015010315626_CIT0002","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1001\/jama.1993.03500030088038","article-title":"Defining the group A streptococcal toxic shock syndrome. Rationale and consensus definition","volume":"269","author":"The Working Group on Severe Streptococcal Infections","year":"1993","journal-title":"JAMA"},{"key":"key\n\t\t\t\t20181015010315626_CIT0003","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.3201\/eid1508.090264","article-title":"Predictors of death after severe Streptococcus pyogenes infection","volume":"15","author":"Lamagni","year":"2009","journal-title":"Emerg Infect Dis"},{"key":"key\n\t\t\t\t20181015010315626_CIT0004","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1093\/jac\/dkl173","article-title":"Human intravenous immunoglobulin for experimental streptococcal toxic shock: bacterial clearance and modulation of inflammation","volume":"58","author":"Sriskandan","year":"2006","journal-title":"J Antimicrob Chemother"},{"key":"key\n\t\t\t\t20181015010315626_CIT0005","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1086\/376630","article-title":"Intravenous immunoglobulin G therapy in streptococcal toxic shock syndrome: a European randomized, double-blind, placebo-controlled trial","volume":"37","author":"Darenberg","year":"2003","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20181015010315626_CIT0006","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1086\/515199","article-title":"Canadian Streptococcal Study Group","volume":"28","author":"Kaul","year":"1999","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20181015010315626_CIT0007","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1093\/cid\/ciu304","article-title":"Effectiveness of clindamycin and intravenous immunoglobulin, and risk of disease in contacts, in invasive group A streptococcal infections","volume":"59","author":"Carapetis","year":"2014","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20181015010315626_CIT0008","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1093\/cid\/ciu449","article-title":"Clinical efficacy of polyspecific intravenous immunoglobulin therapy in patients with streptococcal toxic shock syndrome: a comparative observational study","volume":"59","author":"Linn\u00e9r","year":"2014","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20181015010315626_CIT0009","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1136\/archdischild-2013-304741","article-title":"Toxic shock syndrome surveillance in UK children","volume":"99","author":"Adalat","year":"2014","journal-title":"Arch Dis Child"},{"key":"key\n\t\t\t\t20181015010315626_CIT0010","doi-asserted-by":"crossref","first-page":"1679","DOI":"10.1016\/S0012-3692(15)50887-8","article-title":"Morbidity and mortality of patients with invasive group A streptococcal infections admitted to the ICU","volume":"130","author":"Mehta","year":"2006","journal-title":"Chest"},{"key":"key\n\t\t\t\t20181015010315626_CIT0011","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1086\/606048","article-title":"Intravenous immunoglobulin in children with streptococcal toxic shock syndrome","volume":"49","author":"Shah","year":"2009","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20181015010315626_CIT0012","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1093\/cid\/ciw871","article-title":"Impact of intravenous immunoglobulin on survival in necrotizing fasciitis with vasopressor-dependent shock: a propensity-score matched analysis from 130 US hospitals","volume":"64","author":"Kadri","year":"2016","journal-title":"Clin Infect Dis"}],"container-title":["Clinical Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/cid\/article-pdf\/67\/9\/1434\/26038370\/ciy401.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,4]],"date-time":"2025-07-04T07:59:09Z","timestamp":1751615949000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/cid\/article\/67\/9\/1434\/4996609"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,5,18]]},"references-count":12,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2018,5,18]]},"published-print":{"date-parts":[[2018,10,15]]}},"URL":"https:\/\/doi.org\/10.1093\/cid\/ciy401","relation":{},"ISSN":["1058-4838","1537-6591"],"issn-type":[{"value":"1058-4838","type":"print"},{"value":"1537-6591","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2018,11,1]]},"published":{"date-parts":[[2018,5,18]]}}}